Suppr超能文献

伴有缺血性心脏病的重度抑郁症:帕罗西汀和去甲替林对心率非线性和混沌指标的影响

Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on measures of nonlinearity and chaos of heart rate.

作者信息

Yeragani Vikram K, Roose Steven, Mallavarapu Mallika, Radhakrishna R K A, Pesce Vanessa

机构信息

Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, Mich, USA.

出版信息

Neuropsychobiology. 2002;46(3):125-35. doi: 10.1159/000066390.

Abstract

Depression is associated with increased cardiovascular mortality in patients with preexisting cardiac illness. A decrease in cardiac vagal function as suggested by a decrease in heart rate variability (HRV) or heart period variability has been linked to sudden death in patients with cardiac disease as well as in normal controls. Recent studies have shown decreased vagal function in cardiac patients with depression as well as in depressed patients without cardiac illness. In this study, we compared 20 h awake and sleep heart period nonlinear measures using quantification of nonlinearity and chaos in two groups of patients with major depression and ischemic heart disease (mean age 59-60 years) before and after 6 weeks of treatment with paroxetine or nortriptyline. Patients received paroxetine, 20-30 mg/day or nortriptyline targeted to 190-570 nmol/l for 6 weeks. For HRV analysis, 24 patients were included in the paroxetine treatment study and 20 patients in the nortriptyline study who had at least 20000 s of awake data. The ages of these groups were 60.4 +/- 10.5 years for paroxetine and 60.8 +/- 13.4 years for nortriptyline. There was a significant decrease in the largest Lyapunov exponent (LLE) after treatment with nortriptyline but not paroxetine. There were also significant decreases in nonlinearity scores on S(netPR) and S(netGS) after nortriptyline, which may be due to a decrease in cardiac vagal modulation of HRV. S(netGS) and awake LLE were the most significant variables that contributed to the discrimination of postparoxetine and postnortriptyline groups even with the inclusion of time and frequency domain measures. These findings suggest that nortriptyline decreases the measures of chaos probably through its stronger vagolytic effects on cardiac autonomic function compared with paroxetine, which is in agreement with previous clinical and preclinical reports. Nortriptyline was also associated with a significant decrease in nonlinearity scores, which may be due to anticholinergic and/or sympatholytic effects. As depression is associated with a strong risk factor for cardiovascular mortality, one should be careful about using any drug that adversely affects cardiac vagal function.

摘要

抑郁症与已有心脏疾病患者的心血管死亡率增加有关。心率变异性(HRV)或心动周期变异性降低所提示的心脏迷走神经功能减退,已与心脏病患者以及正常对照者的猝死相关联。近期研究表明,患有抑郁症的心脏病患者以及无心脏病的抑郁症患者的迷走神经功能均有所下降。在本研究中,我们使用非线性和混沌量化方法,比较了两组患有重度抑郁症和缺血性心脏病(平均年龄59 - 60岁)的患者在接受帕罗西汀或去甲替林治疗6周前后20小时清醒和睡眠状态下的心动周期非线性指标。患者接受20 - 30毫克/天的帕罗西汀或目标浓度为190 - 570纳摩尔/升的去甲替林治疗6周。对于HRV分析,帕罗西汀治疗研究纳入了24例患者,去甲替林研究纳入了20例患者,这些患者至少有20000秒的清醒数据。帕罗西汀组的年龄为60.4±10.5岁,去甲替林组的年龄为60.8±13.4岁。去甲替林治疗后最大Lyapunov指数(LLE)显著降低,而帕罗西汀治疗后未出现这种情况。去甲替林治疗后S(netPR)和S(netGS)的非线性得分也显著降低,这可能是由于HRV的心脏迷走神经调节作用减弱所致。即使纳入了时域和频域指标,S(netGS)和清醒状态下的LLE仍是区分帕罗西汀治疗后组和去甲替林治疗后组的最显著变量。这些发现表明,与帕罗西汀相比,去甲替林可能通过对心脏自主神经功能更强的迷走神经阻滞作用降低混沌指标,这与先前的临床和临床前报告一致。去甲替林还与非线性得分显著降低有关,这可能是由于抗胆碱能和/或抗交感神经作用。由于抑郁症与心血管死亡率的一个强风险因素相关,因此在使用任何对心脏迷走神经功能有不利影响的药物时都应谨慎。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验